NCT03523546Active, not recruiting
Oncology Episode Payment Model in Hawaii
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 7 (actual)
- First submitted
- 19 Apr 2018
- Start date
- 1 Aug 2018
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- University of Pennsylvania
- Diseases
- Lung cancer, Colorectal cancer
- NCT number
- NCT03523546
What you commit to
- Study type: Interventional
- Participants enrolled: 7
- From 1 Aug 2018 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Any provider who does not practice with Hawaii Oncology.
Who the study is looking for
- Any oncologist who practices with Hawaii Oncology and is a participating provider.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hawaii Oncology Coordinator of this site? Confirm its status | Honolulu | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.